Daihan Pharmaceutical Co.,Ltd.
Research Daihan Pharmaceutical Co.,Ltd. (023910.KQ) on Bullrun: market cap KRW 152.59B, dividend yield 3.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker023910.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 152.59B
- Dividend yield3.9%
- Financial periodQ2 2026
- RevenueKRW 56.61B
- Net incomeKRW 6.75B
- Free cash flowKRW 12.69B
- Gross margin29.6%
Valuation Snapshot
latest market cap is KRW 152.59B; dividend yield is 3.9%.
Peer valuation comparison
Latest dividend yield is 3.85% versus a Healthcare sector median of 2.4% (60.4% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 152.59B | n/a | 3.9% | 1000 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1000 KRW, yield 3.9%.
About Daihan Pharmaceutical Co.,Ltd.
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Daihan Pharmaceutical Co.,Ltd.'s market cap?
Daihan Pharmaceutical Co.,Ltd.'s market capitalization is KRW 152.59B.
Does Daihan Pharmaceutical Co.,Ltd. pay a dividend?
Daihan Pharmaceutical Co.,Ltd. has a dividend yield of 3.9%.
What does Daihan Pharmaceutical Co.,Ltd. do?
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.